ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "health status"

  • Abstract Number: 1157 • ACR Convergence 2020

    Health and Socioeconomic Outcomes in a Neonatal-Onset Multisystem Inflammatory Disease (NOMID) Cohort Followed for a Median of Fifteen Years

    Sara Alehashemi1, Megha Garg2, Kim Johnson3, Kelly King4, Chris Zalewski4, Debbie Payne5, Adriana de Jesus6, Joseph Snow7, Wadih Zein5, M. Teresa Magone5, Rachel Bishop8, Carmen Brewer4, Jeff Kim4, Scott Paul9, John Butman10 and Raphaela Goldbach-Mansky11, 1Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Clarksville, MD, 2NIH/NIAID, Rochester, NY, 3NIH, NIAID, Bethesda, 4NIH, NIDCD, Bethesda, MD, 5NIH/NEI, Bethesda, MD, 6Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Silver Spring, MD, 7NIH, NIMH, Bethesda, MD, 8NIH, NEI, Bethesda, MD, 9NIH, CC/RMD, Bethesda, MD, 10NIH, CC/DRD, Bethesa, MD, 11Translational Autoinflammatory Disease Section (TADS)/NIAID/NIH, Potomac, MD

    Background/Purpose: Patients (pts) with NOMID have systemic inflammation and organ damage such as sensorineural hearing loss, hydrocephalus, optic nerve atrophy and growth plate defects. IL-1 blocking…
  • Abstract Number: 1287 • ACR Convergence 2020

    Prevalence of Morbidity Prior to Diagnosis of Incident Systemic Lupus Erythematosus in the Danish Population

    Julia Simard1, Mikkel Faurschou2, Soeren Jacobsen2 and Renata Hansen2, 1Stanford Medicine, Stanford, CA, 2Copenhagen Lupus and Vasculitis Clinic, Copenhagen, Denmark

    Background/Purpose: Patients with SLE experience a high burden of various comorbidities at disease onset and during disease progression. Studies of excess morbidity prior to SLE…
  • Abstract Number: 1890 • ACR Convergence 2020

    Daily Management of Patients with Axial Spondyloarthritis: Self-monitoring of Disease Activity with a Smartphone App Is Feasible – a Proof of Concept Study

    Uta Kiltz1, Robin Kempin1, Jutta Richter2, Anna Schlegel1, Xenofon Baraliakos1, Styliani Tsiami3, Ioana Andreica1, Bjoern Buehring4, David Kiefer1 and Juergen Braun1, 1Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany, 2Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, Duesseldorf, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 4Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Velbert, Germany

    Background/Purpose: Assessment and monitoring of disease activity and functioning is of major importance for the course of axial spondyloarthritis (axSpA). This is equally important for…
  • Abstract Number: 264 • 2018 ACR/ARHP Annual Meeting

    Relationships between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus

    Kimberly DeQuattro1, Laura Trupin1, Jing Li1, Patricia Katz2, Cristina Lanata1, Edward H. Yelin3, Stephanie Rush3, Lindsey A. Criswell2, Louise Murphy4, Maria Dall'Era5 and Jinoos Yazdany1, 1Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, 2University of California San Francisco, San Francisco, CA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 4Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 5University of California, San Francisco, San Francisco, CA

    Background/Purpose: Adverse childhood experiences (ACEs) such as abuse, neglect and domestic violence are associated with poor adult health status and immune dysregulation. The extent and…
  • Abstract Number: 2538 • 2017 ACR/ARHP Annual Meeting

    Change in Self-Reported Health Status and Fatigue before and after the Diagnosis of Psoriatic Arthritis- the Nord-Trondelag Health Study (HUNT)

    Mari Hoff1, Tom Ivar Lund Nilsen2, Ruth Stoklund Thomsen3, Agnete Malm Gulati4, Arthur Kavanaugh5 and Glenn Haugeberg4, 1Rheumatolgy, University Hospital, St. Olavs Hospital, NTNU, Trondheim, Norway, 2Faculty of medicine, Department of public health and nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 3Faculty of Medicine, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 4NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 5Medicine, University of California, San Diego, La Jolla, CA

    Background/Purpose: Psoriatic arthritis (PsA) is a systemic inflammatory disease that can involve skin, nails, joints, enthuses, and can be associated with systemic symptoms such as…
  • Abstract Number: 396 • 2015 ACR/ARHP Annual Meeting

    A Comparison of the Illness Experience Reported Via the Patient Reported Outcomes Measurement Information System Between Patients with Childhood-Onset Systemic Lupus Erythematosus, Juvenile Idiopathic Arthritis, and Widespread Chronic Musculoskeletal Pain

    Michael J. Holland1, Jordan Jones1, Esi M. Morgan DeWitt2, Susmita Kashikar-Zuck3, David D. Sherry4, Adam C. Carle5, Bin Huang6, Constance Mara7 and Hermine I. Brunner1, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Behavioral Medicine & Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 5University of Cincinnati Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 7James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: The Patient Reported Outcomes Measurement Information System (PROMIS¨), developed by the National Institutes of Health, seeks to create standardized instruments to measure patient reported…
  • Abstract Number: 121 • 2013 ACR/ARHP Annual Meeting

    Comparative Burden Of Chronic Widespread Pain and Fibromyalgia In The US Population

    Caroline Schaefer1, Rachael Mann2, Elizabeth T. Masters3, Joseph C. Cappelleri4, Shoshana Daniel5, Gergana Zlateva3, Heather McElroy6, Arthi B. Chandran3, Edgar H. Adams1, Annlouise R. Assaf4, Michael McNett7, Philip Mease8, Stuart L. Silverman9 and Roland Staud10, 1Covance Market Access Services Inc., Gaithersburg, MD, 2Covance Market Access Services Inc., San Diego, CA, 3Pfizer Inc., New York, NY, 4Pfizer Inc., Groton, CT, 5Covance Market Access Services Inc., Conshohocken, PA, 6Covance Market Access Services, Sydney, Australia, 7Aurora Pain Program, Milwaukee, WI, 8Director, Rheumatology Research, Swedish Medical Center, Seattle, WA, 9Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA, 10Dept Med/Rheum/Clin Immun Div, University of Florida, Gainesville, FL

    Background/Purpose: Few data exist on the comparative burden of chronic widespread pain (CWP) and fibromyalgia (FM) in the general population. Methods: 8,382 nationally representative participants…
  • « Previous Page
  • 1
  • 2
  • 3
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology